Court sides with Teva over Emergent in generic Narcan suit

Teva Pharmaceuticals is facing a difficult road ahead, thanks to 3,500 cases of litigation surrounding its role in the US opioid epidemic. But the manufacturer got a victory last week when a US appeals court upheld a 2020 finding that ruled in favor of the company in a lawsuit accusing the giant of patent violations.